These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38378781)

  • 1. Cases of trisomy 21 and trisomy 18 among historic and prehistoric individuals discovered from ancient DNA.
    Rohrlach AB; Rivollat M; de-Miguel-Ibáñez P; Moilanen U; Liira AM; Teixeira JC; Roca-Rada X; Armendáriz-Martija J; Boyadzhiev K; Boyadzhiev Y; Llamas B; Tiliakou A; Mötsch A; Tuke J; Prevedorou EA; Polychronakou-Sgouritsa N; Buikstra J; Onkamo P; Stockhammer PW; Heyne HO; Lemke JR; Risch R; Schiffels S; Krause J; Haak W; Prüfer K
    Nat Commun; 2024 Feb; 15(1):1294. PubMed ID: 38378781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.
    Dar P; Jacobsson B; MacPherson C; Egbert M; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Edwards L; Haeri S; Silver R; Vohra N; Hyett J; Clunie G; Demko Z; Martin K; Rabinowitz M; Flood K; Carlsson Y; Doulaveris G; Malone C; Hallingstrom M; Klugman S; Clifton R; Kao C; Hakonarson H; Norton ME
    Am J Obstet Gynecol; 2022 Aug; 227(2):259.e1-259.e14. PubMed ID: 35085538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic outcomes following a failed cell-free DNA screen: a population-based retrospective cohort study of 35,146 singleton pregnancies.
    Bellai-Dussault K; Meng L; Howley H; Reszel J; Huang T; Lanes A; Walker MC; Okun N; Dougan SD; Armour CM
    Am J Obstet Gynecol; 2023 Aug; 229(2):168.e1-168.e8. PubMed ID: 36627072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacing the combined test by cell-free DNA testing in screening for trisomies 21, 18 and 13: impact on the diagnosis of other chromosomal abnormalities.
    Syngelaki A; Pergament E; Homfray T; Akolekar R; Nicolaides KH
    Fetal Diagn Ther; 2014; 35(3):174-84. PubMed ID: 24525399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free DNA analysis in maternal plasma in cases of fetal abnormalities detected on ultrasound examination.
    Benachi A; Letourneau A; Kleinfinger P; Senat MV; Gautier E; Favre R; Bidat L; Houfflin-Debarge V; Bouyer J; Costa JM;
    Obstet Gynecol; 2015 Jun; 125(6):1330-1337. PubMed ID: 26000504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].
    Wei Y; Wang R; Xi M; Wei L; Zhu W; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):933-938. PubMed ID: 37532491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
    Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IONA test for first-trimester detection of trisomies 21, 18 and 13.
    Poon LC; Dumidrascu-Diris D; Francisco C; Fantasia I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):184-7. PubMed ID: 26387684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
    Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A
    Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RETIRED: Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma.
    Langlois S; Brock JA;
    J Obstet Gynaecol Can; 2013 Feb; 35(2):177-181. PubMed ID: 23470070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
    Nicolaides KH; Syngelaki A; Poon LC; Gil MM; Wright D
    Fetal Diagn Ther; 2014; 35(3):185-92. PubMed ID: 24192489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal age and the risk of fetal aneuploidy: A nationwide cohort study of more than 500 000 singleton pregnancies in Denmark from 2008 to 2017.
    Elmerdahl Frederiksen L; Ølgaard SM; Roos L; Petersen OB; Rode L; Hartwig T; Ekelund CK; ; Vogel I
    Acta Obstet Gynecol Scand; 2024 Feb; 103(2):351-359. PubMed ID: 37986093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
    Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
    Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe.
    Stumm M; Entezami M; Haug K; Blank C; Wüstemann M; Schulze B; Raabe-Meyer G; Hempel M; Schelling M; Ostermayer E; Langer-Freitag S; Burkhardt T; Zimmermann R; Schleicher T; Weil B; Schöck U; Smerdka P; Grömminger S; Kumar Y; Hofmann W
    Prenat Diagn; 2014 Feb; 34(2):185-91. PubMed ID: 24222400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.
    Papageorghiou AT; Khalil A; Forman M; Hulme R; Mazey R; Mousa HA; Johnstone ED; McKelvey A; Cohen KE; Risley M; Denman W; Kelly B
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):188-93. PubMed ID: 26493543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Cell-free DNA and Screening for Trisomies.
    Norton ME
    N Engl J Med; 2022 Oct; 387(14):1322-1324. PubMed ID: 36170494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.